Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
710 (USA) · Dr. Silva
consented 2013-01-05
AEs
4
Serious
0
Dropout signal
–
Adverse events
mild
assessed
Mild ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-02-24 (study day 51.0); relationship: POSSIBLE
mild
assessed
Mild ERYTHEMA — outcome: RECOVERED/RESOLVED; onset 2013-02-24 (study day 51.0); relationship: POSSIBLE
mild
assessed
Mild NASOPHARYNGITIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-01-31 (study day 27.0); relationship: NONE
mild
assessed
Mild NASOPHARYNGITIS — outcome: RECOVERED/RESOLVED; onset 2013-01-31 (study day 27.0); relationship: NONE
Data queries
No data queries.